ArcoScreen SA

ArcoScreen SA is an EPFL spin off founded in July 2021 in Lausanne. We are specialized in the development of tools for G protein coupled receptors (GPCRs) drug discovery. Our revolutionary technology enables the prediction of a drug’s efficacy rapidly and early in the drug discovery process (lead optimization and mode of action identification) before expensive clinical trials. Our mission is to revolutionize drug discovery to improve patients’ lives.